Roohi Mariam Peter has been a journalist at Labiotech since 2023. She writes news articles and in-depth features on healthcare, biopharma, science, fundraising, markets, and emerging therapies. She ...

The only TIL therapy approved so far is Amtagvi for melanoma. Here are six companies with promising TIL therapies in the ...

Human immunodeficiency virus (HIV) research has come a long way since the virus was discovered in the 1980s. Antiretroviral therapy (ART) marked a turning point in HIV treatment, changing the lives of ...

Roche's AXELIOS 1 enters next generation DNA sequencing. Can it or rivals unseat Illumina's long-standing market dominance?

With 10 cases in 2025, Guinea worm could be the second disease ever eradicated. Here is what makes disease eradication ...

New therapies in the clinic for bipolar disorder hope to meet unmet needs of efficacy and minimal side effects.

Over the last decade, Poland has seen the rise of its biotech industry. While the country’s pharmaceutical industry has traditionally focused on developing generics, many of these companies have ...

First, let’s take a look at the private biotech investments in June 2026, breaking them down by value, location, funding type, and therapeutic subsector. Last month, NewLimit was the company to raise ...

Novartis’ current strategy can be traced back to October 2023, when the Swiss pharma completed the spin-off of Sandoz, its generics and biosimilars business. The company described the move as the ...

What readers will learn: Reduce manual effort through one automated, closed T cell manufacturing workflow, transferred across multiple sites with reproducible outcomes. Strengthen QC readiness through ...

Biotech associations play a crucial role in advancing the industry by connecting biotech companies, pharmaceutical firms, academic institutions, research organizations, policymakers, and investors.